Activation of Antitumor Agent Gilvocarcins by Visible Light
- 6 January 1984
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 223 (4631) , 69-71
- https://doi.org/10.1126/science.6229029
Abstract
Gilvocarcins that are antitumor agents are activated by low doses of visible light to induce bacteriophage lambda in Escherichia coli. This result is dependent on interaction with DNA. Gilvocarcin M, an analog without antitumor activity, failed to induce the prophage after light exposure, thus demonstrating a correlation between photosensitizing and antitumor activities. These results raise several possibilities regarding the mode of action of gilvocarcins as antitumor agents in vivo, involving light or enzymatic activating systems, which could be exploited in human cancer therapy.This publication has 20 references indexed in Scilit:
- Ravidomycin (AY-25,545),a new antitumor antibiotic.The Journal of Antibiotics, 1983
- Differences in the cleavage of DNA by bleomycin under light (300–350 nm) and dark conditionsCancer Letters, 1982
- PHOTOSENSITIZED DEGRADATION OF DNA BY DAUNOMYCINPhotochemistry and Photobiology, 1982
- Gilvocarcins, new antitumor antibiotics. 4. Mode of action.The Journal of Antibiotics, 1982
- The structure of ravidomycinCanadian Journal of Chemistry, 1981
- Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E.The Journal of Antibiotics, 1981
- Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation.The Journal of Antibiotics, 1981
- Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities.The Journal of Antibiotics, 1981
- Studies on the effects of the antitumor agent camptothecin and derivatives on deoxyribonucleic acidBiochemical Pharmacology, 1980
- A colorimetric assay of lysogenic induction designed for screening potential carcinogenic and carcinostatic agentsEnvironmental Mutagenesis, 1979